Cure JM hosted a special Town Hall featuring Dr. Kaveh Ardalan, Co-Director of the Duke Children’s Myositis Center, a Cure JM Center of Excellence. The session focused on the critical topic of tapering medications in the treatment of juvenile myositis. Families gained practical insights on managing infusions, flares, and daily medications, and had the opportunity to ask questions in a supportive, community-focused environment. The session offered both education and encouragement for those navigating the complex process of medication tapering.
FAQs about the RESET-Myositis Trial for CAR-T
1. What is Cabaletta’s RESET Myositis trial? RESET-Myositis is a phase 1/2 clinical trial being conducted to evaluate the effects of the investigational cell treatment
